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Objectives. This study examined whether stimulation of aden- 
osine receptors before ischemia enhances myocardial resistance to 
stunning in vivo. 
Background. We previously demonstrated the attenuation of 
myocardial stunning by ischemic preconditioning through aden- 
osine receptor activation in rabbits. 
Methods. 1) To confirm the efficacy of an intravenous infusion 
of adenosine to stimulate adenosine receptors in the heart, we 
assessed the effect of an adenosine infusion on the inotropic 
response to an isoproterenol challenge. 2) Myocardial stunning 
was induced by 10 min of coronary occlusion and reperfusion. The 
regional thickening fraction was monitored by an epicardial 
Doppler sensor. Rabbits were pretreated with either no drug 
(control group), adenosine, 8-phenyltheophylline or a combina- 
tion of 8-phenyltheophylline plus adenosine. 
Results. An intravenous infusion of adenosine at 0.15 mg/kg 
body weight per rain attenuated by 50% the elevation of left 
ventricular dP/dtma xby isoproterenol (0.075 #g/kg per min). The 
same dose of adenosine infused for 15 rain before ischemia 
significantly improved the postischemic recovery of the thickening 
fraction, and the thickening fraction at 30 rain reperfusion was 
76.8 ± 3.3% (mean -4-- SE) of the baseline value, which was 
significantly higher than the control value (42.9 -+ 4.5%). The 
relation between thickening fraction and systolic left ventricular 
pressure after reperfusion was shifted toward higher thickening 
fraction by adenosine. This beneficial effect of adenosine was not 
detected in rabbits given 8-phenyltheophylline b fore adenosine, 
and 8-phenyltheophylline-treated rabbits showed a time course of 
thickening fraction similar to that in the control group. 
Conclusions. An intravenous infusion of adenosine is capable of 
protecting rabbit hearts against stunning through adenosine 
receptor activation. 
(J Am Coll Cardiol 1996;27:225-33) 
Myocardium rendered severely ischemic becomes akinetic or 
dyskinetic, and restoration of myocardial perfusion does not 
normalize contractile function despite a lack of infarction until 
hours or even days later. This postischemic contractile dysfunc- 
tion was first found in animal experiments and was termed 
myocardial stunning. Recent clinical studies (1-3) revealed 
that the human heart is stunned by anginal attack, ischemia 
causing myocardial infarction and cardiac surgery, and thus 
myocardial stunning is now recognized as a therapeutic target. 
Although several classes of agents have been shown to atten- 
uate myocardial stunning in animal models (4-12), all have 
limitations in clinical use. For example, beta-adrenergic ago- 
nists are capable of reversing the depressed contractility in 
stunned myocardium (4,5), but they frequently induce unde- 
sirable ventricular arrhythmias in patients with ischemic heart 
disease. 
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Recently, the cardioprotective effects of ischemic precondi- 
tioning against myocardial infarction have been given much 
attention by investigators (13). In a recent study (14), we found 
that myocardial stunning is also alleviated by preconditioning 
with 1 rain of ischemia in rabbit hearts. Furthermore, this effect 
of preconditioning was abolished by an adenosine receptor 
blocker, 8-phenyltheophylline (14), suggesting the involvement 
of adenosine receptor activation. If this is indeed the case, it is 
possible that adenosine infusion mimics preconditioning and 
could be a therapeutic approach to myocardial stunning. The 
present study aimed to test this possibility. We used the same 
rabbit preparation as in our previous studies (7,10,12,14) 
because of two advantages of this model of stunning: 1) The 
level of xanthine oxidase in the heart, which contributes to 
myocardial stunning by generating oxygen-free radicals (15), is 
low in rabbits (16,17), as it is in humans (17-19), in contrast to 
that in rats and dogs (16-19). 2) The variation of myocardial 
stunning by the coronary collateral blood flow (20) does not 
need to be considered in this collateral artery-deficient species 
(2a). 
The dose of adenosine was selected so as not to reduce the 
systemic blood too greatly, thus minimizing the alteration of 
ventricular afterload. To confirm the activation of cardiac 
adenosine receptors by a relatively low dose of adenosine, we 
© 1996 by the American College of Cardiology (1735-1097/96/$15.00 
0735-1 (197(95)00412-2 
226 OGAWA ET AL. JACC Vol. 27, No. 1 
ADENOSINE ON MYOCARDIAL  STUNNING January 1996:225-33 
assessed whether adenosine infusion could suppress inotropic 
response to beta-adrenergic stimulation. 
Control group : Vehicle 
ADO group : Adenosine 
Methods  
This study conformed to the Guidelines of Sapporo Medi- 
cal University on Animal Usage. 
Experiment 1: effect of intravenous adenosine infusion on 
inotropic response to isoproterenoi. This series of experi- 
ments was performed to test whether the dose of adenosine 
that we selected (0.15 mg/kg body weight per min) was 
sufficient o stimulate adenosine receptors in rabbit hearts in 
situ. 
Surgical preparation. Male albino rabbits (Japanese white, 
n = 5) weighing 2.0 to 2.5 kg were anesthetized with pento- 
barbital (30 mg/kg intravenously) and ventilated with a Har- 
vard rodent respirator (model 684) using room air and an 
oxygen supplement. Ventilation rate and oxygen flow were 
adjusted to maintain arterial blood gas within the physiologic 
range. The chest was opened by left thoracotomy, and the 
heart was exposed. A catheter-tipped manometer (Nihon- 
Kohden CTD-096N) was placed in the left ventricle through 
the left atrium, and fluid-filled catheters were inserted into the 
right carotid artery for blood pressure monitoring and into the 
jugular and femoral veins for drug infusion. Precordial elec- 
trodes were placed across the chest wall for electrocardio- 
graphic (ECG) monitoring. Left ventricular pressure and its 
first time derivative (left ventricular dP/dt), left ventricular 
end-diastolic pressure, systemic blood pressure and the ECG 
were continuously recorded on an eight-channel direct-writing 
recorder (Nihon-Kohden WT-687G). 
Experimental protocol. After a 10-min stabilization period, 
baseline hemodynamic variables were measured, and isopro- 
terenol was infused intravenously at0.075 ~g/kg per rain for 
5 min, at which time the hemodynamic data were collected. 
The isoproterenol infusion was then discontinued, and the 
rabbit's heart was allowed to recover for -15 min. After heart 
rate, blood pressure and left ventricular dP/dt returned to 
baseline levels, adenosine was administered intravenously at
0.15 mg/kg per min for 20 rain, during which time the 
isoproterenol challenge was repeated. Finally, 5 min after 
discontinuation of adenosine and isoproterenol infusions, 
10 mg/kg of 8-phenyltheophylline was injected intravenously. 
The response to isoproterenol with an adenosine infusion was 
reassessed 10 rain later. 
Experiment 2: effect of adenosine infusion before ischemia 
on myocardial stunning. Surgical preparation. Male albino 
rabbits (n = 31) were prepared under pentobarbital nesthe- 
sia; a catheter-tipped manometer was placed in the left ven- 
tricle, and fluid-filled catheters were placed in the carotid 
artery and jugular veins, as in Experiment 1. Then, 4-0 silk 
thread was passed around the marginal branch of the left 
coronary artery using a taper needle to make a coronary snare. 
In addition, a single epicardial Doppler sensor (22) was 
secured with 6-0 stitches to the epicardium in the territories of 
the coronary branch. The Doppler sensor was connected to a 
L__ 
15 min 10 rain Occ 30 min Rep 
8-PT group : Vehicle 
8-PT/ADO group : Adenosine 
10 min 15 rain 10 rain Occ 30 min Rep 
Figure 1. Experimental protocols in Experiment 2. Protocols for the 
control and adenosine (ADO) groups (top) and for the 8-phenyltheo- 
phylline (8-PT) and 8-phenyltheophylline/adenosine (8-PT/ADO) 
groups (bottom). All rabbits underwent 10 min of coronary occlusion 
(Occ) and 30 min of reperfusion (Rep). Rabbits were intravenously 
given either saline (control group) or 0.15 mg/kg per rain of adenosine 
(adenosine group) for 15 min, starting 15 min before coronary 
occlusion and stopped just before coronary occlusion. In the 8- 
phenylthcophylline/adenosine group, 10 mg/kg of 8-phenyltheophyl- 
line was injected intravenously as a bolus 25 rain before the coronary 
occlusion, and adenosine was administered in the same way as in the 
adenosine group. In the 8-phenyltheophylline group, only 8-phenyl- 
theophylline was administered. 
Pulsed Doppler Dimension System VF-1 (Crystal Biotech) to 
measure the regional thickening fraction. The systolic thicken- 
ing fraction was calculated as the ratio of the difference 
between end-systolic and end-diastolic wall thickness to end- 
diastolic thickness, multiplied by 100 (22). The onset of systole 
was determined as the initial increase in left ventricular dP/dt, 
and the end of systole was considered tobe coincident with the 
peak negative left ventricular dP/dt. For each sample period, 
hemodynamic variables and the thickening fraction were mea- 
sured for at least 5 beats and then averaged. 
Experimental protocol. As shown in Figure 1, rabbits were 
assigned to four experimental groups, and myocardial stunning 
was induced by 10 rain of coronary artery occlusion and 
reperfusion. The group that received only vehicle (saline) 
served as the control group. The adenosine group received 
adenosine at 0.15 mg/kg per min intravenously for 15 rain 
before ischemia, and the adenosine infusion was discon- 
tinued immediately before coronary occlusion. In the 8- 
phenyltheophylline/adenosine group, the rabbits were pre- 
treated with 10 mg/kg of 8-phenyltheophylline at 25 min 
before the ischemia nd then given an adenosine infusion, as 
in the adenosine group. Only 8-phenyltheophylline was 
administered in the 8-phenyltheophylline group. 
Experiment 3: effect of adenosine pretreatment on high 
energy phosphates and lactate. Surgicalpreparation a d exper- 
imental protocol. Male albino rabbits (n = 10) were anesthe- 
tized with pentobarbital, the heart was exposed, and a coronary 
snare was placed as in Experiment 2.In addition, a fluid-filled 
catheter was inserted into the left atrium. Rabbits were 
assigned to two groups, and both groups underwent 10 min of 
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Table 1. Summary ofHemodynamic Variables in Experiment 1 
Baseline IP ADO ADO + IP 8-PT 8-PT + ADO 8-PT + ADO + IP 
HR (beats/min) 276 + 13 308 _+ 10" 291 + 13 306 _+ 13" 296 +- 18' 290 _+ 19' 308 _+ 19' 
SBP (ram Hg) 90 +_ 5 87_+ 2 81 _+ 3 79 ÷ 4* 91 -+ 6 89 +- 5 95 _+ 3 
DBP (ram Hg) 70 + 5 66 + 2 56 _+ 4* 47 _+ 5*t 75 -+ 7 74 +_ 5 77 +_ 2t 
LV dP/dtm~, (ram Hg/s) 4,024 -+ 375 6,264 -+ 266* 3,964 +- 300t 5,072 +- 196't 3,880 -- 315t 3,810 + 159? 6,290 -+ 177" 
LVEDP (ram Hg) 4.5 +_ 0.3 3.9 +_ 0.4 5.3 _+ 1.1~ 5.5 _+ 0.9t 4.3 +- 0.7 4.7 _+ 0.3 4.7 +_ 0.6 
*p < 0.05 versus baseline. ~p < 0.05 versus isoproterenol (IP) infusion (0.075 ~g/kg per min). Data presented are mean value -+ SE. ADO = adenosine infusion 
(0.15 mg/kg per min); DBP = diastolic blood pressure; dP/dtm~ , = maximum of first derivative of left ventricular (LV) pressure; EDP = end-diastolic pressure; HR = 
heart rate; SBP = systolic blood pressure; 8-PT = 8-phenyltheophylline bolus injection (10 mg/kg). 
coronary artery occlusion. One group of rabbits received a 
saline infusion, and the other was given the same dose of 
adenosine intravenously as in Experiment 2 (0.15 mg/kg per 
min) for 15 rain of the preischemic period. After 10 min of the 
ischemic period, Monastral blue dye was injected into the left 
atrium, and the heart was quickly excised and immediately 
immersed in an ice-cold isotonic potassium chloride solution. 
Transmural myocardial tissues were transected from the nonisch- 
emic region (the region stained with Monastral blue dye) and 
from the ischemic region (the region not stained with the blue 
dye) and stored in liquid nitrogen until assay. The time interval 
between the excision of the heart and freezing of the heart 
tissue in liquid nitrogen was < 1 rain. 
Tissue metabolite assay. Myocardial tissue samples (100 to 
500 mg) were lyophilized and homogenized in ice-cold 0.6 N 
perchloric acid. The homogenate was centrifuged at3,000 rpm, 
-4°C, to obtain the supernatant, which was neutralized with 
30% potassium hydroxide and then centrifuged again. The 
recentrifuged supernatant was used for an enzymatic assay of 
adenine nucleotidcs and lactate (23). 
Statistics. Differences in heart weight and tissue metabo- 
lite levels were tested by one-way analysis of variance 
(ANOVA). The difference between the variables in each group 
for the various time periods of measurement was tested by a 
repeated-measures ANOVA. The time course of the thicken- 
ing fraction and hemodynamic variables between the experi- 
mental groups were compared using two-way ANOVA with 
the Greenhouse-Geisser co rection (24). The difference in 
linear egression lines was tested by analysis of covariance. The 
ANOVA was conducted by using STATISTICA (Statsoft, 
Inc.). Results are reported as mean value + SE. 
Results 
Experiment 1. Alterations in hemodynamic variables dur- 
ing isoproterenol and adenosine infusion are summarized in
Table 1. Isoproterenol infusion increased heart rate and left 
ventricular dP/dtma × by -30 beats/min and 2,200 mm Hg/s, 
respectively, whereas mean blood pressure was slightly re- 
duced. An adenosine infusion blunted the response to isopro- 
terenol, and elevation of left ventricular dP/dtmax was attenu- 
ated by -50% during adenosine infusion. This inhibitory effect 
of adenosine was not detected after an 8-phenyltheophylline 
injection. These results uggest that an intravenous infusion of 
adenosine at 0.15 mg/kg per min is sufficient o activate 
adenosine r ceptors in rabbit hearts in situ, which suppressed 
adenylate cyclase activity stimulated by the beta-receptor ago- 
nist. 
Experiment 2. Hemodynamic data during ischemia/ 
repeffusion are summarized in Table 2. Under baseline con- 
ditions, heart rate, blood pressure and left ventricular end- 
diastolic pressure were comparable inall experimental groups. 
Mean blood pressure immediately before coronary occlusion 
was slightly lower in the adenosine group than in the 8- 
phenyltheophylline group, but there was no significant differ- 
ence between the adenosine and control groups. Elevation of 
left ventricular end-diastolic pressure during coronary occlu- 
sion was also similar in all groups. 
Under baseline conditions, the regional systolic thickening 
fraction was comparable inall study groups: 14.2 + 1.2% in the 
control group, 11.3 -+ 0.6% in the adenosine group, 12.3 +_ 
0.5% in the 8-phenyltheophylline/adenosine group and 13.8 + 
2.0% in the 8-phenyltheophylline group. For a clear presenta- 
tion of the effect of drugs on postischemic recovery of the 
thickening fraction, Figure 2 illustrates the time course of the 
thickening fraction, which was normalized by the baseline 
values. In the control group, the thickening fraction was 
reduced to approximately -40% during ischemia. After reper- 
fusion, the thickening fraction gradually improved but re- 
mained epressed at 42.9 + 4.5% of the baseline value after 
30 rain of reperfusion. In the adenosine group, the thickening 
fraction during the reperfusion period was consistently higher 
than that in the control group at corresponding time points and 
recovered to 76.8 +_ 3.3% of baseline at 30 rain after reperfu- 
sion (Fig. 2A). These time courses of postischemic recovery of 
the thickening fraction in the adenosine and control groups 
were significantly different by two-way repeated-measures 
ANOVA. Conversely, the time course and extent of post- 
ischemic recovery of the thickening fraction in the 8- 
phenyltheophylline/adenosine and 8-phenyltheophylline 
groups were not different from those in the control group (Fig. 
2, B and C). 
Because alteration i left ventricular afterload and myocar- 
dial oxygen consumption (12) could have influenced postisch- 
emic recovery of the thickening fraction, we plotted the 
thickening fraction against he left ventricular systolic pressure 
at 30 rain of reperfusion (Fig. 3) and against he rate-pressure 
products immediately before the coronary occlusion (Fig. 4). 
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Table 2. Summary  of  Hemodynamic  Var iab les  in Exper iment  2 
Variable and 
Study Group Baseline Prc-Occ Occlusion Rep 1 rain Rep 30 rain 
HR (beats/rain) 
Control 256 -+ 11 254 -+ 11 252 _+ 12 247 + 11 246 z 13 
ADO 253 z 10 258 _+ 11 259 _+ 10 251 + 10 250 _+ 12 
8-PT 248 + 16 269 + 22 265 -+ 21 248 _+ 20 249 + 21 
8-PT/ADO 249 -+ 8 259 z 11 260 -+ 12 256 + 9 253 _+ 6 
SBP (mm Hg) 
Control 88 -+ 6 87 -+ 6 78 -+ 6 82 + 7 79 z 6 
ADO 85 -+ 5 81 -+ 5 79_+ 4 83 _+ 5 84_+ 5 
8-PT 99 _+ 7 98 + 8 94 _+ 8 90 + 7 91 -- 9 
8-PT/ADO 95 = 6 98 -+ 6 90 -+ 4 94 + 9 89 _+ 4 
DBP (mm Hg) 
Control 69 -+ 6 69 -+ 6 60 -+ 6 65 _~ 7 63 +_ 6 
ADO 68 -+ 4 57 + 5 60 + 4 64 + 4 66 _+ 4 
8-PT 78 + 6 77 -+ 8 76 -+ 7 69 + 6 70 _+ 9 
8-PT/ADO 70 -+ 6 76 -+ 5 71 -+ 4 70 + 7 67 _+ 4 
RPP (x l00)  
Control 225 _+ 20 225 + 21 199 -~ 22 205 _+ 24 200 + 24 
ADO 218 _+ 17 213 _+ 19 186 _+ 19 212 + 18 212 x 19 
8-PT 248 + 28 265 _+ 33 251 + 33 229 +_ 32 232 _+ 37 
8-PT/ADO 238 -+ 24 257 -+ 25 237 -+ 20 241 _+ 25 227 _+ 14 
LVEDP (ram Hg) 
Control 2.8 _+ 0.6 2.7 _+ 0.5 5.5 _+ 0.8 3.6 _- 0.9 3.3 _+ 0.7 
ADO 2.9 _+ 0.4 3.8 + 0.4 5.3 + 0.5 3.9 _+ 0.4 4.2 _+ 0.5 
8-PT 5.2 + 0.5 5.0 + 0.6 7.0 + 0.6 4.4 _+ 0.7 4.0 _+ 0.6 
8-PT/ADO 3.7 -+ 0.3 3.9 -+ 0.3 6.4 + 0.9 4.4 -- 0.5 4.3 _+ 0.4 
Data presented are mean value _+ SE. Occlusion - 1 min after coronary occlusion; Pre-Occ = 1 min before coronary 
occlusion; Rep 1 min = 1 min after reperfusion; Rep 30 min = 30 min after reperfusion; RPP = rate-pressure product; 
other abbreviations a  in Table 1. 
Correlation between the thickening fraction and the concur- 
rent left ventricular systolic pressure did not reach statistical 
significance in the control group (y -- 42.39 - 0.01x, r = -0.01, 
p = NS), but a correlation was observed in the adenosine 
group (y = 110.76 - 0.40x, r = -0.59, p < 0.05) (Fig. 3). These 
two regression lines differ in intercepts, but slopes were not 
significantly different by analysis of covariance, suggesting an 
upward shift of the relation by adenosine. Similarly, the 
relation between rate-pressure products before ischemia nd 
the thickening fraction 30 rain after eperfusion was significant 
only in the adenosine group, and the regression line for this 
group had larger y-intercepts han those for the control group, 
although its slope was not significantly different from that in 
the control group (y = 101.0 - 1.14 x 10 3x, r = -0.66, p < 
0.05, vs. y = 45.5 - 0.17 X 10 Sx, r = -0.31, p = NS). 
Experiment 3. Table 3 summarizes the data of adenine 
nucleotide metabolites and lactate in the myocardium. The 
levels of myocardial denosine triphosphate (ATP), adenosine 
diphosphate, adenosine monophosphate, energy charge poten- 
tial and lactate in the nonischemic region were comparable 
between the control and adenosine-treated rabbits. The levels 
of ATP and the other adenine nucleotides and energy charge 
potential were lowered to similar levels in ischemic myocar- 
dium in both the control and the adenosine-treated rabbits. 
However, tissue lactate accumulation i  the ischemic myocar- 
dium was significantly less in the adenosine-treated group than 
in the control group (108.1 _+ 19.8 vs. 165.3 _+ 7.5/xmol/g dry 
weight, p < 0.05). 
Discussion 
In the present study, regional contractile dysfunction after 
10 rain of ischemia was improved by an adenosine infusion 
before the ischemia, and this improvement of contractile 
function was not accompanied bysignificant alterations of left 
ventricular end-diastolic pressure or systolic left ventricular 
pressure. Cardioprotection byan adenosine infusion was com- 
pletely abolished by pretreatment with 8-phenyltheophylline. 
These findings suggest hat activation of adenosine receptors 
before ischemia may enhance myocardial resistance against 
stunning in rabbit hearts in situ. 
Etficacy of adenosine infusion. An intravenous infusion is 
an easily accessible route in the clinical setting. However, it is 
not an ideal method for delivering adenosine to the myocar- 
dium because a large part of the adenosine is taken up by red 
blood cells (25) and vascular endothelial cells (26,27) before it 
reaches the cardiomyocytes. Thus, we first tried to confirm the 
efficacy of an intravenous infusion of adenosine for activating 
myocardial denosine receptors. It is well known that adeno- 
sine At receptor activation suppresses adenylate cyclase activ- 
ity stimulated by beta-adrenoceptor activation (28). As shown 
in Table 1, 0.15 mg/kg per rain of adenosine significantly 
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attenuated the inotropic response to an isoproterenol chal- 
lenge without concurrent changes in left ventricular end- 
diastolic pressure or heart rate. Systolic blood pressure was 
slightly reduced during adenosine infusion; however, this 
Figure 2. Effect of adenosine (ADO) and 8-phenyltheophylline (8-PT) 
on the regional systolic thickening fraction during 10 min of ischemia 
and 30 rain of reperfusion. The thickening fraction was normalized by 
the baseline values. A, Control group versus adenosine group. B, 
Control group versus 8-phenyltheophylline group. C, Control group 
versus 8-phenyltheophylline/adenosine group. The adenosine group 
received adenosine intravenously at 0.15 mg/kg per min for 15 rain 
before coronary artery occlusion. The 8-phenyltheophylline group was 
given 10 mg/kg of 8-phenyltheophylline 25 min before the 10 rain of 
ischemia. The 8-phenyltheophylline/adenosine groupreceived both an 
injection of 8-phenyltheophylline a d an adenosine infusion (see Fig. 
1 for details). There was significant difference inthe time course of the 
thickening fraction between the control and adenosine groups (A) by 
two-way repeated-measures analysis of variance with the Greenhouse- 
Geisser correction. Oc = 1 rain after coronary occlusion; Pre-Oc = 
point just before coronary artery occlusion (end point of adenosine 
infusion). 
( 
would not cause overestimation, but rather underestimation f 
the negative inotropic effect of adenosine on left ventricular 
dP/dtma ×. It is unlikely that beta-adrenoceptors were desensi- 
tized by the first transient 5-min infusion of isoproterenol, 
causing the blunted response to the second isoproterenol 
challenge. Furthermore, the effect of adenosine on the ino- 
tropic response to the beta-adrenoceptor agonist was blocked 
by 8-phenyltheophylline, a nonselective adenosine receptor 
blocker. These results indicate that the present dose of aden- 
osine was sufficient for activating adenosine receptors in the 
ventricular myocytes in the open chest rabbit preparation. 
Effect of adenosine infusion on regional contractile func- 
tion. One limitation of the present study is that we assessed 
myocardial stunning using the systolic thickening fraction. This 
index of the systolic thickening fraction reflects contractility 
but is also influenced by heart rate and ventrieular load. 
However, heart rate was the same for all study groups, and left 
ventricular end-diastolic pressure was similar during both the 
ischemic and reperfusion periods, suggesting that ventricular 
preload was comparable in all the groups. However, there was 
Figure 3. Scatterplot f thickening fraction versus ystolic left ventric- 
ular pressure at 30 rain after reperfusion. There was a weak inverse 
correlation between the two variables in the adenosine group (solid 
circles) (y = 110.76 - 0.40x, r = -0.592, p < 0.05) but not in the 
control group (open circles) (y -- 42.39 - 0.01x, r = -0.008, p = NS). 
The regression line for the adenosine group has a larger y-intercept 
than that for the control group, but the slopes were not statistically 
different. 
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Figure 4. Scatterplot showing relation between the thickening fraction 
at 30 rain after repcrfusion and rate-pressure product (RPP) immedi- 
ately before coronary artery occlusion. In the adenosine group (solid 
circles), the thickening fraction at 30 rain after reperfusion correlated 
with the rate-pressure product before ischemia (y = 101.0 - 1.14 × 
10 3x, r = -0.66, p < 0.05), but there was no significant correlation in 
the control group (open circles) (y = 45.5 - 0.17 × 10 3x, r = -0.31, 
p = NS). The regression line for the adenosine group has a larger 
y-intercept han that for the control group, but slopes were not 
statistically different. 
a weak correlation between the thickening fraction and systolic 
left ventricular pressure 30 rain after reperfusion (Fig. 3). This 
correlation suggests that a slight reduction in ventricular 
afterload could partially contribute to the improved regional 
contractile function by adenosine. However, Figure 3 shows 
that the thickening fraction 30 rain after reperfusion was 
higher in the adenosine-treated group than in the control 
group, regardless of the level of systolic pressure; that is, the 
regression line in the adenosine group was shifted upward to 
the control data with essentially no overlap. This finding 
suggests that an afterload-independent ffect of adenosine also 
improved the thickening fraction during reperfusion. Taken 
together, the present dose of adenosine had a beneficial effect 
on contractile dysfunction after ischemia by two mechanisms: 
reduction in ventricular afterload and attenuation of myocar- 
dial stunning. As seen in Figure 3, the latter mechanism 
appears predominant over the former in the present prepara- 
tion. 
One possible explanation for the attenuation of myocardial 
stunning by adenosine may be an improvement in myocardial 
oxygen supply/demand balance as a result of the reduction of 
myocardial oxygen demand by this agent. A recent study (12) 
from our laboratory showed that an -20% reduction in 
rate-pressure products before ischemia by verapamil s capable 
of attenuating myocardial stunning. Furthermore, there was 
strong correlation between the postischemic thickening frac- 
tion and preischemic rate-pressure products in verapamil- 
pretreated rabbits (12). In the present study, the thickening 
fraction after reperfusion correlated with rate-pressure prod- 
ucts before coronary occlusion in adenosine-treated rabbits, 
but there was no significant correlation in the control group 
(Fig. 4). However, the regression line in the adenosine group 
was shifted upward to the control data, indicating that a 
reduction in myocardial oxygen demand by adenosine alone 
cannot explain the improved postischemic recovery of contrac- 
tion. 
Although it was not statistically significant, the baseline 
thickening fraction in the adenosine group tended to be 
somewhat lower than the values in the other groups. To test 
whether this slight difference in the baseline thickening frac- 
tion contributed to a higher recovery of the normalized 
thickening fraction in the adenosine group (Fig. 2A), we 
plotted the normalized thickening fraction at 30 rain after 
reperfusion against he absolute value of the thickening frac- 
tion under baseline conditions in each rabbit. As shown in 
Figure 5, recovery of the normalized thickening fraction was 
inversely correlated with the absolute values of the baseline 
thickening fraction in the untreated control rabbits (r = -0.70, 
p < 0.05). However, improvement in recovery of the thicken- 
ing fraction in the adenosine group was independent of the 
baseline thickening fraction; the regression line for the aden- 
osine group had a significantly larger y-intercept than that in 
the control group, and the slopes of those two regression lines 
were similar. The relations in the 8-phenyltheophylline/ 
adenosine and 8-phenyltheophylline groups were similar to 
those of the untreated controls (Fig. 5). These results indicate 
that the higher recovery of the normalized thickening fraction 
after reperfusion in the adenosine groups cannot be attributed 
to their slightly lower absolute thickening fraction before the 
onset of myocardial ischemia. 
Effect of adenosine infusion on myocardial metabolism. In 
adenosine-treated rabbits, lactate accumulation i the myocar- 
dium during 10 rnin of ischemia was 35% less than that in the 
untreated control group (Table 3). This result suggests that 
glycolysis was suppressed in adenosine-treated hearts, because 
washout of lactate from the ischemic region should be negli- 
Table 3. Summary of Myocardial Metabolites 
Treatment n ATP ADP AMP TAN ECP Lactate 
Nonischemic region 
Control 5 19.4 _+ 1.7 4.3 + 0.6 1.6 _+ 0.6 25.6 _+ 1.6 0.9 ± 0.0 32.8 _+ 14.9 
Adenosine 5 18.1 _+ 1.8 6.3 + 0.9 2.8 + 0.4 27.2 * 2.4 0.8 _+ 0.0 30.7 _+ 6.1 
Ischemic region 
Control 5 8.4 ± 0.7 4.4 _+ 1.1 3.2 -- 0.3 16.0 -- 1.4 0.7 ± 0.0 165.3 + 7.5 
Adenosine 5 8.6 ± 0.8 6.4 _+ 0.4 2.9 _+ 0.5 17.9 _+ 1.2 0.7 ± 0.0 108.1 ± 19.8" 
*p < 0.05 versus control. Data are expressed as/zmol/g dry weight, mean value _+ SE. ADP adenosine diphosphate; 
AMP = adenosine monophosphate; ATP = adenosine triphosphate; Control - vehicle (saline); ECP = energy charge 
potential; n = number of samples; TAN - total adenine nucleotide. 
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Figure 5. Scatterplot showing the relation between the thickening 
fraction at 30 min after reperfusion and the absolute value of 
thickening fraction before the onset of myocardial ischemia. Open 
triangles = 8-phenyltheophylline/adenosine group; open squares = 
8-phenyltheophylline group. In the control group (open circles), there 
was significant inverse correlation between the two variables (y = 
81.4 - 2.7x, r = -0.70, p < 0.05), and the regression li e is shown. In 
the adenosine group (solid circles), the thickening fraction at 30 min 
after reperfusion was clearly higher than that in the control group 
regardless of the thickening fraction at baseline, and the regression 
line for the adenosine group (y = 97.6 - 1.9x, r = -0.33, p = 0.35) has 
a larger y-intercept than the control regression li e, although t e slope 
was not statistically different inthe two groups. The relation between 
percent recovery ofthe thickening fraction and the baseline thickening 
fraction in the 8-phenyltheophylline/adenosine and 8-phenyltheophyl- 
line groups was similar to that in the control group. 
gible in collateral-channel deficient rabbit hearts (21). Con- 
versely, ATP after 10 rain of ischemia was not different 
between adenosine-treated and untreated rabbits, although 
earlier studies (29-32) have reported a deceleration i ATP 
depletion during ischemia by adenosine receptor activation. 
However, if glycolysis (and thus anaerobic ATP synthesis) was 
indeed suppressed by the adenosine infusion, a similar level of 
ATP in the adenosine-treated and untreated rabbits might 
reflect suppressed ATP consumption during ischemia in 
adenosine-pretreated hearts. 
A limitation of the tissue metabolite analysis in the present 
experiments was a delay in the freezing of the myocardial 
tissues after the sampling. As stated in Methods, it took 30 s to 
1 rain to excise the heart and separate the nonischemic and 
ischemic tissues in ice-cold potassium chloride solution before 
dipping the tissue samples in liquid nitrogen. This delay would 
have caused ischemic alterations in the metabolism in both 
nonischemic and ischemic samples. Although we do not have 
direct data for how much ATP degradation and lactate accu- 
mulation might have occurred during the cooling process, 
Jennings et al. (33) previously evaluated this possibility in 
canine hearts. By comparisons with tissue metabolite l vels in 
the samples quickly frozen by a precooled rongeur and those in 
the tissues ampled as in the present study, they showed that 
ATP and ADP levels were not changed within 1 to 3 rain of 
ischemia, whereas creatine phosphate was depleted by 70%, 
and lactate levels increased approximately threefold. These 
data suggest hat the adenine nucleotide levels were main- 
tained by consumption of creatine phosphate and anaerobic 
glycolysis during that time period. Thus, the tissue lactate 
levels in the nonischemic region may have been somewhat 
overestimated in the present study, but data for adenine 
nucleotide l vels are considered to be reasonable estimates of
the values in vivo, and we believe that interpretation f the 
effect of adenosine infusion on tissue ATP and lactate during 
coronary occlusion was not seriously compromised by the 
technical limitation. 
Intracellular mechanism of action. In the present study, 
the intracellular mechanism through which adenosine r ceptor 
activation enhances myocardial resistance against stunning was 
not clarified. However, a few possible explanations can be 
suggested. 
1. Suppression of glyeolysis during ischemia by adenosine 
(34) could result in less accumulation f proton and of sodium 
through sodium-proton exchange during ischemia (35). This 
would lead to less calcium overload in the myocyte through a
sodium-calcium exchange (36). This explanation is supported 
by a recent study by Fralix et al. (30), who showed that 
pretreatment with adenosine delayed the accumulation of 
proton and calcium during global ischemia in isolated rat 
hearts. 
2. An infusion of adenosine may activate the Aa-receptor- 
linked ATP-sensitive potassium channel (KATP), thus enhanc- 
ing myocardial tolerance against stunning. This explanation is
supported by a recent study in our laboratory (10) using the 
same rabbit preparation. That study showed that an infusion of 
nicorandil, a KAX e opener, before ischemia was capable of 
attenuating stunning (10), and this cardioprotection was abol- 
ished by glibenclamide, a blocker of KAy p. Similar results were 
also obtained in canine models of myocardial stunning (9). 
3. Eckert et al. (37) found that in isolated myocytes, 
adenosine receptor activation decreases the calcium current 
but increases the intracellular calcium level. This response was 
attenuated by ryanodine and thapsigargin and mimicked by 
inositol 1,4,5-trisphosphate, which suggests that calcium re- 
lease from the intracellular store may cause an elevation of 
intracellular calcium after adenosine r ceptor activation. If this 
is the case, adenosine receptor activation might deplete cal- 
cium in its intracellular store sites and thus suppress the 
calcium overload from this source during ischemia/reperfusion 
(37). However, this explanation isnot supported by a study by 
Fralix et al. (30), who did not detect any significant elevation of 
the intracellular calcium level during an adenosine infusion. 
This discrepancy in the observation of the effect of adenosine 
on intracellular calcium may be caused by a difference in the 
dose of adenosine or the conditions of the myocytes (isolated 
myocytes vs. crystalloid-perfused whole heart). 
Possible species difference. The present findings are con- 
sistent with earlier studies using isolated rat hearts (30,38), in 
which preischemic treatment with adenosine significantly im- 
proved the recovery of the global contractile function from 10 
to 30 min of ischemia. Although "stunning" of the isolated 
hearts may not be strictly comparable with stunned myocar- 
dium in vivo (39), those studies support he hypothesis that 
adenosine receptor activation before ischemia enhances myo- 
cardial tolerance against stunning. In contrast, two studies 
using canine in vivo models (40,41) failed to observe that a 
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large dose of adenosine or 2-chloro-N6-cyclopentyladenosine, 
an Al-receptor agonist, could precondition the myocardium 
against myocardial stunning. The failure of the adenosine 
infusion to attenuate the stunning cannot be explained by the 
dose of adenosine (4 mg/min), because one-tenth of that dose 
infused for 10 rain was shown to precondition the canine heart 
successfully against infarction (42). A recent study using a 
swine preparation (43) also could not detect any significant 
attenuation of myocardial stunning by infusion of adenosine 
into the left atrium during the preischemic period. However, 
these different outcomes of preischemic administration of 
adenosine among the canine (40,41), swine (43), rabbit (Fig. 2) 
and rat (30,38) hearts appear comparable to the different 
results of ischemic preconditioning against stunning in these 
species (14,44-46). Myocardial stunning was attenuated by 
preconditioning, which was abolished by 8-phenyltheophylline, 
in the rabbit heart (14). Similarly, Steenbergen et al. (44) 
found that preconditioning the isolated rat heart with four 
cycles of 5 rain of ischemia and 5 rain of reperfusion signifi- 
cantly improved recovery of left ventricular pressure from 
30 min of ischemia. Furthermore, the protective effect of 
preconditioning on contractile function was prevented by 
8-sulfophenyltheophylline. Because infarct size limitation 
by preconditioning in rat hearts was not blocked by 8- 
sulfophenyltheophylline (47), the improved contractile func- 
tion by preconditioning in the Steenbergen et al. (44) study is 
most likely attributable to attenuation of stunning. In contrast, 
various protocols of preconditioning reportedly failed to pro- 
tect the canine and swine hearts against stunning (42,46). It is 
unclear why both adenosine and preconditioning protect the 
heart against stunning in the rabbit (14) and rat (30,44) but not 
in the dog and pig (40,41,43,45,46). A possible explanation is 
that a modest improvement in contractile function by adeno- 
sine and preconditioning might have been masked by the 
variation in stunning because of various collateral flow levels in 
the dog (19), and the beneficial effect was detectable in 
collateral flow-independent models of stunning (i.e., collateral- 
channel deficient rabbit hearts and isolated rat hearts). How- 
ever, this does not explain the negative results in the swine 
heart, in which the native coronary collaterals are poorly 
developed, as in the rabbit and the rat. Possible differences in 
the extent of KAy P activation after adenosine receptor stimu- 
lation and in the level of free radical production on reperfusion 
(48) may be responsible for the contradictory findings. How- 
ever, there is no clear evidence supporting these speculations. 
Conclusions. Adenosine receptor stimulation before isch- 
emia significantly enhances myocardial resistance against stun- 
ning in the rabbit heart in situ. This adenosine-mediated 
protection may play a role in attenuation of myocardial 
stunning by ischemic preconditioning in rabbits. 
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